C4722085 |
Malignant neoplasm of colon and/or rectum
|
disease |
|
Neoplastic Process
|
|
|
3669 |
502 |
C3854222 |
Human immunodeficiency virus (HIV) II infection category B1
|
disease |
|
Disease or Syndrome
|
|
|
985 |
56 |
C0751606 |
Adult Acute Lymphocytic Leukemia
|
disease |
|
Neoplastic Process
|
disease of anatomical entity; disease of cellular proliferation
|
|
860 |
154 |
C2363741 |
HIV-1 infection
|
disease |
|
Disease or Syndrome
|
|
|
695 |
94 |
C0392885 |
High density lipoprotein measurement
|
phenotype |
|
Laboratory Procedure
|
|
|
545 |
1440 |
C0202117 |
Low density lipoprotein cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
|
|
483 |
1142 |
C1282496 |
Metastasis from malignant tumor of prostate
|
disease |
|
Neoplastic Process
|
|
|
342 |
18 |
C0428472 |
Serum HDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
|
|
283 |
679 |
C0428474 |
Serum LDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
|
|
269 |
555 |
C0032181 |
Platelet Count measurement
|
phenotype |
|
Laboratory Procedure
|
|
|
265 |
457 |
C0023980 |
Longevity
|
phenotype |
|
Temporal Concept
|
|
|
48 |
74 |
C3548801 |
response to irinotecan
|
phenotype |
|
Cell Function
|
|
|
1 |
7 |
C0020538 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
disease of anatomical entity
|
Abnormality of the cardiovascular system
|
2322 |
1085 |
C0041755 |
Adverse reaction to drug
|
group |
Chemically-Induced Disorders
|
Pathologic Function
|
|
|
87 |
0 |
C0013221 |
Drug toxicity
|
group |
Chemically-Induced Disorders
|
Injury or Poisoning
|
|
|
86 |
0 |
C0013146 |
Drug abuse
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
disease of mental health
|
|
405 |
39 |
C1510472 |
Drug Dependence
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
|
|
248 |
31 |
C0038586 |
Substance Use Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
|
|
218 |
16 |
C0013170 |
Drug habituation
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
|
|
196 |
19 |
C0740858 |
Substance abuse problem
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
|
|
185 |
20 |
C0038580 |
Substance Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
|
|
156 |
19 |
C0236969 |
Substance-Related Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
disease of mental health
|
|
128 |
20 |
C0013222 |
Drug Use Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
|
|
121 |
0 |
C0029231 |
Organic Mental Disorders, Substance-Induced
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
|
|
115 |
0 |
C4316881 |
Prescription Drug Abuse
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Finding
|
|
|
115 |
0 |